|
|
||||||||



* Molecular Biomedicine, Swiss Federal Institute of Technology, and
Cytos Biotechnology AG, Zurich-Schlieren, Switzerland;
Institute for Experimental Immunology, Zurich, Switzerland; and
Department of Immunology, Serono Pharmaceutical Research Institute, Geneva, Switzerland
Osteopontin (OPN) has been defined as a key cytokine promoting the release of IL-12 and hence inducing the development of protective cell-mediated immunity to viruses and intracellular pathogens. To further characterize the role of OPN in antiviral immunity, OPN-deficient (OPN/) mice were analyzed after infection with influenza virus and vaccinia virus. Surprisingly, we found that viral clearance, lung inflammation, and recruitment of effector T cells to the lung were unaffected in OPN/ mice after influenza infection. Furthermore, effector status of T cells was normal as demonstrated by normal IFN-
production and CTL lytic activity. Moreover, activation and Th1 differentiation of naive TCR transgenic CD4+ T cells by dendritic cells and cognate Ag was normal in the absence of OPN in vitro. Contrary to a previous report, we found that OPN/ mice mounted a normal immune response to Listeria monocytogenes. In conclusion, OPN is dispensable for antiviral immune responses against influenza virus and vaccinia virus.
This article has been cited by other articles:
![]() |
E. L. Karcher, D. O. Bayles, J. P. Bannantine, D. C. Beitz, and J. R. Stabel Osteopontin: A Novel Cytokine Involved in the Regulation of Mycobacterium avium subspecies paratuberculosis Infection in Periparturient Dairy Cattle J Dairy Sci, August 1, 2008; 91(8): 3079 - 3091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |